(Press-News.org) Tampa, FL (June 4, 2012) Those cups of coffee that you drink every day to keep alert appear to have an extra perk – especially if you're an older adult. A recent study monitoring the memory and thinking processes of people older than 65 found that all those with higher blood caffeine levels avoided the onset of Alzheimer's disease in the two-to-four years of study follow-up. Moreover, coffee appeared to be the major or only source of caffeine for these individuals.
Researchers from the University of South Florida (www.usf.edu) and the University of Miami (www.miami.edu)say the case control study provides the first direct evidence that caffeine/coffee intake is associated with a reduced risk of dementia or delayed onset. Their findings will appear in the online version of an article to be published June 5 in the Journal of Alzheimer's Disease, published by IOS Press (http://health.usf.edu/nocms/publicaffairs/now/pdfs/JAD111781.pdf). The collaborative study involved 124 people, ages 65 to 88, in Tampa and Miami.
"These intriguing results suggest that older adults with mild memory impairment who drink moderate levels of coffee -- about 3 cups a day -- will not convert to Alzheimer's disease -- or at least will experience a substantial delay before converting to Alzheimer's," said study lead author Dr. Chuanhai Cao, a neuroscientist at the USF College of Pharmacy (http://health.usf.edu/nocms/pharmacy/) and the USF Health Byrd Alzheimer's Institute (http://health.usf.edu/nocms/byrd/). "The results from this study, along with our earlier studies in Alzheimer's mice, are very consistent in indicating that moderate daily caffeine/coffee intake throughout adulthood should appreciably protect against Alzheimer's disease later in life."
The study shows this protection probably occurs even in older people with early signs of the disease, called mild cognitive impairment, or MCI. Patients with MCI already experience some short-term memory loss and initial Alzheimer's pathology in their brains. Each year, about 15 percent of MCI patients progress to full-blown Alzheimer's disease. The researchers focused on study participants with MCI, because many were destined to develop Alzheimer's within a few years.
Blood caffeine levels at the study's onset were substantially lower (51 percent less) in participants diagnosed with MCI who progressed to dementia during the two-to-four year follow-up than in those whose mild cognitive impairment remained stable over the same period.
No one with MCI who later developed Alzheimer's had initial blood caffeine levels above a critical level of 1200 ng/ml – equivalent to drinking several cups of coffee a few hours before the blood sample was drawn. In contrast, many with stable MCI had blood caffeine levels higher than this critical level.
"We found that 100 percent of the MCI patients with plasma caffeine levels above the critical level experienced no conversion to Alzheimer's disease during the two-to-four year follow-up period," said study co-author Dr. Gary Arendash.
The researchers believe higher blood caffeine levels indicate habitually higher caffeine intake, most probably through coffee. Caffeinated coffee appeared to be the main, if not exclusive, source of caffeine in the memory-protected MCI patients, because they had the same profile of blood immune markers as Alzheimer's mice given caffeinated coffee. Alzheimer's mice given caffeine alone or decaffeinated coffee had a very different immune marker profile.
Since 2006, USF's Dr. Cao and Dr. Arendash have published several studies investigating the effects of caffeine/coffee administered to Alzheimer's mice. Most recently, they reported that caffeine interacts with a yet unidentified component of coffee to boost blood levels of a critical growth factor that seems to fight off the Alzheimer's disease process.
"We are not saying that moderate coffee consumption will completely protect people from Alzheimer's disease," Dr. Cao cautioned. "However, we firmly believe that moderate coffee consumption can appreciably reduce your risk of Alzheimer's or delay its onset."
Alzheimer's pathology is a process in which plaques and tangles accumulate in the brain, killing nerve cells, destroying neural connections, and ultimately leading to progressive and irreversible memory loss. Since the neurodegenerative disease starts one or two decades before cognitive decline becomes apparent, the study authors point out, any intervention to cut the risk of Alzheimer's should ideally begin that far in advance of symptoms.
"Moderate daily consumption of caffeinated coffee appears to be the best dietary option for long-term protection against Alzheimer's memory loss," Dr. Arendash said. "Coffee is inexpensive, readily available, easily gets into the brain, and has few side-effects for most of us. Moreover, our studies show that caffeine and coffee appear to directly attack the Alzheimer's disease process."
In addition to Alzheimer's disease, moderate caffeine/coffee intake appears to reduce the risk of several other diseases of aging, including Parkinson's disease, stroke, Type II diabetes, and breast cancer. However, supporting studies for these benefits have all been observational (uncontrolled), and controlled clinical trials are needed to definitively demonstrate therapeutic value.
A study tracking the health and coffee consumption of more than 400,000 older adults for 13 years, and published earlier this year in the New England Journal of Medicine, found that coffee drinkers reduced their risk of dying from heart disease, lung disease, pneumonia, stroke, diabetes, infections, and even injuries and accidents.
With new Alzheimer's diagnostic guidelines encompassing the full continuum of the disease, approximately 10 million Americans now fall within one of three developmental stages of Alzheimer's disease -- Alzheimer's disease brain pathology only, MCI, or diagnosed Alzheimer's disease. That number is expected to climb even higher as the baby-boomer generation continues to enter older age, unless an effective and proven preventive measure is identified.
"If we could conduct a large cohort study to look into the mechanisms of how and why coffee and caffeine can delay or prevent Alzheimer's disease, it might result in billions of dollars in savings each year in addition to improved quality of life," Dr. Cao said.
###The USF-UM study was funded by the NIH-designated Florida Alzheimer's Disease Research Center and the State of Florida.
High blood caffeine levels in older adults linked to avoidance of Alzheimer's disease
2012-06-05
ELSE PRESS RELEASES FROM THIS DATE:
JEBDP looks at connections between preventive dentistry and public health
2012-06-05
St. Louis, MO, June 4, 2012 – The dental profession needs to build a stronger connection between oral health and general health—not only for individual patients, but also at the community level, according to the special June issue of The Journal of Evidence-Based Dental Practice (JEBDP), the foremost publication of information about evidence-based dental practice, published by Elsevier.
The special issue follows the usual format of JEBDP, comprising expert reviews and analyses of the scientific evidence on specific dental procedures. "Yet the coverage goes beyond a review ...
BUSM researcher finds link between brain signaling and renal function
2012-06-05
(Boston) - Boston University School of Medicine (BUSM) researchers recently uncovered a brain signaling pathway responsible for regulating the renal excretion of sodium. The findings appear in the Journal of the Federation of American Societies for Experimental Biology.
Hypertension, or chronic high blood pressure, affects one-third of adults, significantly increasing cardiovascular risk and mortality. Approximately 50 percent of hypertensive patients are salt-sensitive and exhibit an increase in blood pressure following salt-intake.
According to the researchers, little ...
New immune therapy shows promise in kidney cancer
2012-06-05
BOSTON – An antibody that helps a person's own immune system battle cancer cells shows increasing promise in reducing tumors in patients with advanced kidney cancer, according to researchers at Beth Israel Deaconess Medical Center.
The results of an expanded Phase 1 trial presented at the American Society of Clinical Oncology's annual conference in Chicago, showed that some patients treated with a fully human monoclonal antibody developed by Bristol Myers Squibb had a positive response to the effort by the agent, BMS-936558, to prolong the immune system's efforts to fight ...
Underground search for neutrino properties unveils first results
2012-06-05
Menlo Park, Calif. — Scientists studying neutrinos have found with the highest degree of sensitivity yet that these mysterious particles behave like other elementary particles at the quantum level. The results shed light on the mass and other properties of the neutrino and prove the effectiveness of a new instrument that will yield even greater discoveries in this area.
The Enriched Xenon Observatory 200 (EXO-200), an international collaboration led by Stanford University and the U.S. Department of Energy's (DOE) SLAC National Accelerator Laboratory, has begun one of ...
Vaccinations of US children declined after publication of now-refuted autism risk
2012-06-05
New University of Cincinnati research has found that fewer parents in the United States vaccinated their children in the wake of concerns about a purported link (now widely discredited) between the MMR (measles, mumps, rubella) vaccine and autism.
Lenisa Chang, assistant professor of economics in UC's Carl H. Lindner College of Business, found that the MMR-autism controversy, which played out prominently in the popular media following publication in a 1998 medical journal, led to a decline of about two percentage points in terms of parents obtaining the MMR vaccine for ...
Physicists close in on a rare particle-decay process
2012-06-05
PASADENA, Calif.—In the biggest result of its kind in more than ten years, physicists have made the most sensitive measurements yet in a decades-long hunt for a hypothetical and rare process involving the radioactive decay of atomic nuclei.
If discovered, the researchers say, this process could have profound implications for how scientists understand the fundamental laws of physics and help solve some of the universe's biggest mysteries—including why there is more matter than antimatter and, therefore, why regular matter like planets, stars, and humans exists at all. ...
Emergency department algorithm may predict risk of death for heart failure patients
2012-06-05
Physicians can reduce the number of heart failure deaths and unnecessary hospital admissions by using a new computer-based algorithm developed at the Institute for Clinical Evaluative Sciences (ICES) that calculates each patient's individual risk of death. Published in the Annals of Internal Medicine, the algorithm improves upon clinical decision-making and determines whether or not a patient with heart failure should be admitted to hospital. To bring this tool into the emergency departments, Peter Munk Cardiac Centre cardiologists are developing smartphone and web-based ...
June 2012 story tips from Oak Ridge National Laboratory
2012-06-05
MATERIALS – Transparent performance . . .
Windshields, windows, solar panels, eyeglasses, heart stents and hundreds of other products representing a multi-billion-dollar market are potential targets for Oak Ridge National Laboratory's thin-film superhydrophobic technology. Conventional commercially available products tend to lack transparency, suitable bonding capability or both, making them largely impractical, said Tolga Aytug, one of the developers. The ORNL product, based on glass, can be produced with manufacturing processes that are cost effective and easily scaled ...
Depression treatment can prevent adolescent drug abuse
2012-06-05
DURHAM, N.C. -- Treating adolescents for major depression can also reduce their chances of abusing drugs later on, a secondary benefit found in a five-year study of nearly 200 youths at 11 sites across the United States.
Only 10 percent of 192 adolescents whose depression receded after 12 weeks of treatment later abused drugs, compared to 25 percent of those for whom treatment did not work, according to research led by John Curry, a professor of psychology and neuroscience at Duke University.
"It turned out that whatever they responded to -- cognitive behavioral therapy, ...
Life expectancy prolonged for esophageal cancer patients
2012-06-05
Reston, Va. (June 4, 2012) – For those with esophageal cancer, initial staging of the disease is of particular importance as it determines whether to opt for a curative treatment or palliative treatment. Research presented in the June issue of The Journal of Nuclear Medicine shows that physicians using positron emission tomography (PET)/computed tomography (CT) can discern incremental staging information about the cancer, which can significantly impact management plans.
In 2012, an estimated 17,500 people will be diagnosed with esophageal cancer and 15,000 will die from ...